ACTB May Serve As a Predictive Marker for the Efficacy of Lenvatinib in Patients with HBV-related Early-Stage Hepatocellular Carcinoma Following Partial Hepatectomy: a Retrospective Cohort Study.
JOURNAL OF GASTROINTESTINAL ONCOLOGY（2023）
关键词
Hepatocellular carcinoma (HCC),lenvatinib,hepatitis B virus (HBV),personalized therapy,partial hepatectomy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要